• 1
    Wagner L, Lacey MD. The hidden costs of cancer care: an overview with implications and referral resources for oncology nurses. Clin J Oncol Nurs. 2004;8:279287.
  • 2
    Shelton RC, Goldman RE, Emmons KM, Sorensen G, Allen JD. An investigation into the social context of low-income, urban Black and Latina women: implications for adherence to recommended health behaviors. Health Educ Behav. 2011;38:471481.
  • 3
    Zafar SY, Peppercorn JM, Schrag D, et al. The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience. Oncologist. 2013;18:381390.
  • 4
    Fryback DG, Craig BM. Measuring economic outcomes of cancer. J Natl Cancer Inst Monogr. 2004;(33):134141.
  • 5
    Simmons LA. Self-perceived burden in cancer patients: validation of the Self-perceived Burden Scale. Cancer Nurs. 2007;30:405411.
  • 6
    Gupta D, Lis CG, Grutsch JF. Perceived cancer-related financial difficulty: implications for patient satisfaction with quality of life in advanced cancer. Support Care Cancer. 2007;15:10511056.
  • 7
    Rogers SN, Harvey-Woodworth CN, Hare J, Leong P, Lowe D. Patients' perception of the financial impact of head and neck cancer and the relationship to health related quality of life. Br J Oral Maxillofac Surg. 2012;50:410416.
  • 8
    Sharp L, Carsin AE, Timmons A. Associations between cancer-related financial stress and strain and psychological well-being among individuals living with cancer. Psychooncology. 2013;22:745755.
  • 9
    Meneses K, Azuero A, Hassey L, McNees P, Pisu M. Does economic burden influence quality of life in breast cancer survivors? Gynecol Oncol. 2012;124:437443.
  • 10
    Shankaran V, Jolly S, Blough D, Ramsey SD. Risk factors for financial hardship in patients receiving adjuvant chemotherapy for colon cancer: a population-based exploratory analysis. J Clin Oncol. 2012;30:16081614.
  • 11
    Sedjo RL, Devine S. Predictors of non-adherence to aromatase inhibitors among commercially insured women with breast cancer. Breast Cancer Res Treat. 2011;125:191200.
  • 12
    Byers TE, Wolf HJ, Bauer KR, et al. The impact of socioeconomic status on survival after cancer in the United States: findings from the National Program of Cancer Registries Patterns of Care Study. Cancer. 2008;113:582591.
  • 13
    Sabatino SA, Thompson TD, Richardson LC, Miller J. Health insurance and other factors associated with mammography surveillance among breast cancer survivors: results from a national survey. Med Care. 2012;50:270276.
  • 14
    Brewster AM, Hortobagyi GN, Broglio KR, et al. Residual risk of breast cancer recurrence 5 years after adjuvant therapy. J Natl Cancer Inst. 2008;100:11791183.
  • 15
    American Cancer Society. Cancer Treatment & Survivorship Facts & Figures 2012–2013. Atlanta, GA: American Cancer Society; 2012.
  • 16
    Parry C, Kent EE, Mariotto AB, Alfano CM, Rowland JH. Cancer survivors: a booming population. Cancer Epidemiol Biomarkers Prev. 2011;20:19962005.
  • 17
    Centers for Disease Control and Prevention. National Health Interview Survey (NHIS). Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2011. Accessed January 15, 2013.
  • 18
    Forsythe LP, Kent EE, Weaver KE, et al. Receipt of psychosocial care among cancer survivors in the United States. J Clin Oncol. 2013;31:19611969.
  • 19
    Weaver KE, Forsythe LP, Reeve BB, et al. Mental and physical health-related quality of life among U.S. cancer survivors: population estimates from the 2010 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev. 2012;21:21082117.
  • 20
    Smith AW, Reeve BB, Bellizzi KM, et al. Cancer, comorbidities, and health-related quality of life of older adults. Health Care Financing Rev. 2008;29:4156.
  • 21
    Graubard BI, Korn EL. Predictive margins with survey data. Biometrics. 1999;55:652659.
  • 22
    Weaver KE, Rowland JH, Bellizzi KM, Aziz NM. Forgoing medical care because of cost: assessing disparities in healthcare access among cancer survivors living in the United States. Cancer. 2010;116:34933504.
  • 23
    Short PF, Moran JR, Punekar R. Medical expenditures of adult cancer survivors aged < 65 years in the United States. Cancer. 2011;117:27912800.
  • 24
    Pisu M, Azuero A, McNees P, Burkhardt J, Benz R, Meneses K. The out of pocket cost of breast cancer survivors: a review. J Cancer Surviv. 2010;4:202209.
  • 25
    Finkelstein EA, Tangka FK, Trogdon JG, Sabatino SA, Richardson LC. The personal financial burden of cancer for the working-aged population. Am J Managed Care. 2009;15:801806.
  • 26
    Ell K, Xie B, Wells A, Nedjat-Haiem F, Lee PJ, Vourlekis B. Economic stress among low-income women with cancer: effects on quality of life. Cancer. 2008;112:616625.
  • 27
    Chirikos TN, Roetzheim RG, McCarthy EP, Iezzoni LI. Cost disparities in lung cancer treatment by disability status, sex, and race. Disabil Health J. 2008;1:108115.
  • 28
    Jayadevappa R, Malkowicz SB, Chhatre S, Gallo J, Schwartz JS. Racial and ethnic variation in health resource use and cost for prostate cancer. BJU Int. 2010;106:801808.
  • 29
    Pisu M, Azuero A, Meneses K, Burkhardt J, McNees P. Out of pocket cost comparison between Caucasian and minority breast cancer survivors in the Breast Cancer Education Intervention (BCEI). Breast Cancer Res Treat. 2011;127:521529.
  • 30
    Pezzin LE, O'Niel MB, Nattinger AB. The economic consequences of breast cancer adjuvant hormonal treatments. J Gen Intern Med. 2009;24(suppl 2):S446S450.
  • 31
    Waldron I, Hughes ME, Brooks TL. Marriage protection and marriage selection–prospective evidence for reciprocal effects of marital status and health. Soc Sci Med. 1996;43:113123.
  • 32
    Carver JR, Shapiro CL, Ng A, et al. American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. J Clin Oncol. 2007;25:39914008.
  • 33
    Brooks J, Wilson K, Amir Z. Additional financial costs borne by cancer patients: a narrative review. Eur J Oncol Nurs. 2011;15:302310.
  • 34
    Darby K, Davis C, Likes W, Bell J. Exploring the financial impact of breast cancer for African American medically underserved women: a qualitative study. J Health Care Poor Underserved. 2009;20:721728.
  • 35
    Carey M, Paul C, Cameron E, Lynagh M, Hall A, Tzelepis F. Financial and social impact of supporting a haematological cancer survivor. Eur J Cancer Care. 2012;21:169176.
  • 36
    Grunfeld E, Coyle D, Whelan T, et al. Family caregiver burden: results of a longitudinal study of breast cancer patients and their principal caregivers. CMAJ. 2004;170:17951801.
  • 37
    Mathews M, Park AD. Identifying patients in financial need: cancer care providers' perceptions of barriers. Clin J Oncol Nurs. 2009;13:501505.
  • 38
    Alfano CM, Ganz PA, Rowland JH, Hahn EE. Cancer survivorship and cancer rehabilitation: revitalizing the link. J Clin Oncol. 2012;30:904906.
  • 39
    Longo CJ, Fitch M, Deber RB, Williams AP. Financial and family burden associated with cancer treatment in Ontario, Canada. Support Care Cancer. 2006;14:10771085.
  • 40
    Langa KM, Fendrick AM, Chernew ME, Kabeto MU, Paisley KL, Hayman JA. Out-of-pocket health-care expenditures among older Americans with cancer. Value Health. 2004;7:186194.
  • 41
    Dalhamer JM,Simile CM. Subunit nonresponse in the National Health Interview Survey (NHIS): an exploration using paradata. Joint Statistical Meeting: Section on Government Statistics. Proceedings of the Joint Statistical Meetings, Washington, DC, 2009;262276.
  • 42
    Yabroff KR, Dowling E, Rodriguez J, et al. The Medical Expenditure Panel Survey (MEPS) experiences with cancer survivorship supplement. J Cancer Surviv. 2012;6:407419.